Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02941458

Thoracic Tumours Register

Observational, multicenter study in patients with lung cancer and other thoracic tumors.

The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Thoracic Tumors

Sex eligibility

All sexes

Study type

Observational

Primary location

Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain

Loading trial locations.

About this study

Observational, multicenter study in patients with lung cancer and other thoracic tumors. In a prospective and retrospective way, information will be obtained from the clinical history of each patient.

In Europe, patients with lung cancer have a poor prognosis, and there has been only limited improvement between 1999 and 2007. Potential advantages of the centralization of care and the discussion of treatment strategies in multidisciplinary teams, as suggested in other studies,13 require further research. However, the priorities should be to prevent lung cancer by implementing anti-smoking policies and controlling asbestos exposure throughout Europe, such as was recommended by the World Health Organization (WHO) in 2008.14 Other priorities are to reduce levels of residential radon in risk areas, and early diagnosis to improve the results of surgery, which is still the main curative treatment.

The variability in the diagnostic process, treatment and advocacy, as well as the anticipated increase in associated mortality in Spain in coming years, has stimulated the creation of an epidemiological, observational, multicenter study of cases of lung cancer and other thoracic tumors diagnosed and treated by medical personnel, including both thoracic surgeons and medical oncologists. Data from this study will be collected retrospectively and prospectively, so as to enable an extensive study of the epidemiological and therapeutic factors related to the disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)

Exclusion criteria

  • Patients with other type of tumours

Treatment and study plan

Primary outcomes

  1. Describe epidemiology characteristics of lung cancer and other thoracic tumors in Spanish people

    Time frame: up to 10 years

    To know the epidemiology characteristics of lung cancer and other thoracic tumors in Spain, as well as clinical and histological data, diagnosis, treatments received, and prognostic factors

Study contacts

Contact information is provided by the study sponsor or research team.

Eva Pereira

CONTACT

[email protected]

+34934302006

Sponsors and collaborators

Lead sponsor

Spanish Lung Cancer Group

Other

Registry information

Acronym: RTT

Important dates

Study start
2016
Primary completion
2030
Study completion
2031
First posted
Oct 21, 2016
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.